BiomeSense develops an AI-enabled technology platform for microbiome data generation and analysis. Its GutLab technology enables continuous tracking of gut microbiome throughout treatment journeys, while the MetaBiome AI Platform transforms data using time-series analyses to identify clinically-relevant shifts and patterns. Founded in 2018 in Chicago, United States, the company has raised $8.4M in seed funding from investors including Bluestein Ventures, SOSV, and IndieBio. Developer of AI-enabled technology platform for microbiome data generation and analysis. The company provides continuous, comprehensive microbiome data and AI-enabled bioinformatics. It offers GutLab technology for continuous tracking of the patient's gut microbiome throughout the treatment journey. The company's MetaBiome AI Platform transforms and analyzes the data using time-series analyses, enabling identification of clinically-relevant shifts and patterns.
BiomeSense
SeedBiomeSense develops an AI-enabled technology platform for microbiome data generation and analysis. Its GutLab technology enables continuous tracking of gut microbiome throughout treatment journeys, while the MetaBiome AI Platform transforms data using time-series analyses to identify clinically-relevant shifts and patterns. Founded in 2018 in Chicago, United States, the company has raised $8.4M in seed funding from…
About
Business model
Life Sciences Tech > Research & Development > Scientific Sourcing > Research Groups > Microbiome Research,
Genomics > Applied Genomics > Consumer Genomics > Microbiomics,
SOSV Batches > INDIE.BIO > Cohort 08
Founders & team highlights
Serial Founder
Team background
College Wise > Stanford University, King’s College London, Booth School of Business, University of Chicago
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.